GENE ONLINE|News &
Opinion
Blog

2025-11-29|

Study Explores Link Between Self-Reported Hearing Loss and Cognitive Decline in Older Chinese Adults

by GOAI
Share To

A recent study has examined the relationship between self-reported hearing impairment and cognitive function in older adults in China, a country with a rapidly aging population. Researchers analyzed data from the China Health and Retirement Longitudinal Study (CHARLS) to investigate how hearing loss may influence cognitive trajectories among elderly individuals. The findings shed light on the potential link between hearing difficulties and cognitive decline in this demographic.

The study utilized extensive data collected over several years through CHARLS, which tracks health, economic, and social factors affecting middle-aged and older Chinese adults. By focusing on self-reported cases of hearing impairment, researchers evaluated its impact on cognitive performance over time. The results contribute to a growing body of evidence suggesting that sensory impairments like hearing loss could play a significant role in shaping cognitive health during aging. Further details about the methodology or specific outcomes were not disclosed in the report.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 30, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
LATEST
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
Scroll to Top